|
PNMAL1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.266230E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.055700E-02 |
| Normal-vs-Stage2 |
6.119000E-01 |
| Normal-vs-Stage3 |
3.360900E-03 |
| Normal-vs-Stage4 |
5.772300E-04 |
| Stage1-vs-Stage2 |
3.558000E-02 |
| Stage1-vs-Stage3 |
2.013400E-01 |
| Stage1-vs-Stage4 |
4.399900E-02 |
| Stage2-vs-Stage3 |
1.536270E-02 |
| Stage2-vs-Stage4 |
4.435700E-03 |
| Stage3-vs-Stage4 |
3.559000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.864000E-03 |
| Normal-vs-AfricanAmerican |
8.674000E-01 |
| Normal-vs-Asian |
1.702310E-02 |
| Caucasian-vs-AfricanAmerican |
1.397200E-01 |
| Caucasian-vs-Asian |
7.202800E-01 |
| AfricanAmerican-vs-Asian |
1.184400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.511000E-01 |
| Normal-vs-Female |
7.537300E-03 |
| Male-vs-Female |
4.099000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.883300E-03 |
| Normal-vs-Age(41-60Yrs) |
4.306200E-02 |
| Normal-vs-Age(61-80Yrs) |
1.460790E-01 |
| Normal-vs-Age(81-100Yrs) |
7.679600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.955600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.791400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.402200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.713400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.461600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.490800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.044190E-04 |
| Classical-VS-Follicular |
1.385960E-04 |
| Classical-VS-Other |
9.688400E-01 |
| Classical-VS-Normal |
2.035400E-03 |
| Tall-VS-Follicular |
4.83590001376655E-09 |
| Tall-VS-Other |
2.043400E-01 |
| Tall-VS-Normal |
4.02409999766817E-08 |
| Follicular-VS-Other |
2.362200E-01 |
| Follicular-VS-Normal |
1.865560E-01 |
| Other-VS-Normal |
2.292200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.695000E-01 |
| Normal-vs-N1 |
5.00210000087264E-08 |
| N0-vs-N1 |
3.85999999741315E-08 |
|
|
